Get started
Author

Michelle L. McCully

Observed names: M L McCully, M.L. McCully, Michelle L McCully, Michelle McCully
Observed institutions: Western University, Immunocore (United States), Immunocore (United Kingdom), Institute of Infection and Immunity, Robarts Research Institute, Cardiff University, University of Birmingham
ORCID: 0000-0003-1543-3629
Observed ORCID: 0000-0003-1543-3629
OpenAlex ID: A5031787432
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ TH2 cells
2011 · Sabina A Islam, Daniel S Chang, et al. · Nature Immunology · 316
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome
2009 · Thu A Chau, Michelle L McCully, et al. · Nature Medicine · 139
CCR8 Expression Defines Tissue-Resident Memory T Cells in Human Skin
2018 · Michelle L McCully, Kristin Ladell, et al. · The Journal of Immunology · 103
PDF
Epidermis instructs skin homing receptor expression in human T cells
2012 · Michelle L. McCully, Kristin Ladell, et al. · Blood · 84
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors
2021 · Adam P. Curnock, Giovanna Bossi, et al. · JCI Insight · 80
PDF
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
2017 · Paul J. Collins, Michelle L. McCully, et al. · The FASEB Journal · 76
PDF
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide–HLA Complex
2020 · Charlotte H Coles, Rachel M Mulvaney, et al. · The Journal of Immunology · 53
Immune‐Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B–Infected Cells
2020 · Joannah R. Fergusson, Zoë Wallace, et al. · Hepatology · 52
PDF
The Human Cutaneous Chemokine System
2011 · Michelle L. McCully, Bernhard Moser · Frontiers in Immunology · 41
PDF
Peripheral Tissue Chemokines: Homeostatic Control of Immune Surveillance T Cells
2018 · Michelle L. McCully, Ariadni Kouzeli, et al. · Trends in Immunology · 40
Skin Metabolites Define a New Paradigm in the Localization of Skin Tropic Memory T Cells
2015 · Michelle L McCully, Paul J Collins, et al. · The Journal of Immunology · 30
PDF
Engineering soluble T‐cell receptors for therapy
2021 · Ross A. Robinson, Catriona McMurran, et al. · FEBS Journal · 29
PDF
RIP2 Is Required for NOD Signaling But Not for Th1 Cell Differentiation and Cellular Allograft Rejection
2008 · T. Fairhead, D. Lian, et al. · American Journal of Transplantation · 21
PDF
Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis
2005 · M L McCully, T A Chau, et al. · Clinical & Experimental Immunology · 19
An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis
2024 · Rachel L. Paterson, Marco P. La Manna, et al. · Proceedings of the National Academy of Sciences · 17
PDF
Dendritic Cells as Arbiters of Peritoneal Immune Responses
2006 · Michelle L. McCully, Joaquín Madrenas · Peritoneal Dialysis International · 15
Receptor-Interacting Protein-2 Deficiency Delays Macrophage Migration and Increases Intracellular Infection during Peritoneal Dialysis-Associated Peritonitis
2008 · Michelle L. McCully, Todd Fairhead, et al. · American Journal of Nephrology · 13
Receptor-interacting protein 2 is a marker for resolution of peritoneal dialysis-associated peritonitis
2007 · M.L. McCully, M.L. Baroja, et al. · Kidney International · 11
The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection
2008 · Michelle L McCully, Todd Fairhead, et al. · Expert Review of Molecular Diagnostics · 8
Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM).
2021 · Richard D. Carvajal, Takami Sato, et al. · Journal of Clinical Oncology · 7
Immune mobilising T cell receptors redirect polyclonal CD8+ T cells in chronic HIV infection to form immunological synapses
2022 · Zoë Wallace, Jakub Kopycinski, et al. · Scientific Reports · 6
PDF
1014P Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in previously untreated patients with metastatic uveal melanoma
2021 · A.K.S. Salama, V. Cheshuk, et al. · Annals of Oncology · 4
PDF
538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp
2021 · Joseph Sacco, Richard Carvajal, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Overall survival (OS) in metastatic uveal melanoma: A summary of recent prospective trials.
2022 · Josep M. Piulats, Alexander Noor Shoushtari, et al. · Journal of Clinical Oncology · 2
Su.80. Up-Regulation of Rip2 Expression During Peritonitis Correlates with Clinical Outcome
2006 · Michelle McCully, M Baroja, et al. · Clinical Immunology · 1
Works count: 32
Citation count: 1,170
H-index: 15
I10-index: 18
Year
Topic
Type